Adeno-associated virus type 2 increases proteosome-dependent degradation of p21WAF1 in a human papillomavirus type 31b-positive cervical carcinoma line

Journal of Virology

Volumn 80, Issue 10, 2006, Pages 4927-4939

  Alam, Samina ^a   Sen, Ellora ^a,b   Brashear, Heidi ^a   Meyers, Craig ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NATIONAL BRAIN RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; HISTONE H1 KINASE; PROTAMINE KINASE; PROTEASOME; UNCLASSIFIED DRUG; VIRUS DNA;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 2; ARTICLE; CANCER GROWTH; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA CONTENT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 31B; IMMUNOPRECIPITATION; KERATINOCYTE; PREPUCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SUPERINFECTION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; WESTERN BLOTTING;

CELL CYCLE; CELL LINE; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DEPENDOVIRUS; FEMALE; HUMANS; KERATINOCYTES; PAPILLOMAVIRIDAE; PROTEASOME ENDOPEPTIDASE COMPLEX; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS - 2; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPES;

EID: 33646461383     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.80.10.4927-4939.2006     Document Type: Article

References (85)

1. Adams, P. D., and W. G. Kaelin, Jr. 1996. The cellular effects of E2F overexpression. Curr. Top. Microbiol. Immunol. 208:79-93.
2. Bantel-Schaal, U. 1995. Growth properties of a human melanoma cell line are altered by adeno-associated parvovirus type 2. Int. J. Cancer 60:269-274.
3. Bantel-Schaal, U., and H. zur Hausen. 1984. Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology 134:52-63.
4. Batchu, R. B., M. A. Shammas, J. Y. Wang, J. Freeman, N. Rosen, and N. C. Munshi. 2002. Adeno-associated virus protects the retinoblastoma family of proteins from adenoviral-induced functional inactivation. Cancer Res. 62:2982-2985.
5. Batchu, R. B., M. A. Shammas, J. Y. Wang, and N. C. Munshi. 2001. Dual level inhibition of E2F-1 activity by adeno-associated virus Rep78. J. Biol. Chem. 276:24315-24322.
6. Batchu, R. B., M. A. Shammas, J. Y. Wang, and N. C. Munshi. 1999. Interaction of adeno-associated virus Rep78 with p53: implications in growth inhibition. Cancer Res. 59:3592-3595.
7. Batchu, R. B., M. A. Shammas, J. Y. Wang, R. J. Shmookler Reis, and N. C. Munshi. 2002. Interaction of adeno-associated virus Rep78 with SV40 T antigen: implications in Rep protein expression leading to the inhibition of SV40-mediated cell proliferation. Intervirology 45:115-118.
8. Bedell, M. A., J. B. Hudson, T. R. Golub, M. E. Turyk, M. Hosken, G. D. Wilbanks, and L. A. Laimins. 1991. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J. Virol. 65:2254-2260.
9. Berns, K. I. 1990. Parvovirus replication. Microbiol. Rev. 54:316-329.
10. Blacklow, N. R., G. Cukor, S. Kibrick, and G. Quinnan. 1978. Interactions of adeno-associated viruses with cells transformed by herpes simplex, p. 87-97. In D. C. Ward and P. Tattersall (ed.), Replication of mammalian parvoviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
11. WAF1/CIP1 expression. Biochem. Biophys. Res. Commun. 227:564-569.
12. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah, et al. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
13. WAF1. Pathol. Biol. (Paris) 48:190-202.
14. Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and T. Kouzarides. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601.
15. Carter, B. J. 1990. Adeno-associated virus helper functions, p. 255-295. In P. Tijssen (ed.), Handbook of parvoviruses, vol. 1. CRC Press, Boca Raton, Fla.
16. CIP1. Mol. Cell. Biol. 16:4673-4682.
17. Clark, W., E. J. Black, A. MacLaren, U. Kruse, N. LaThangue, P. K. Vogt, and D. A. Gillespie. 2000. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity. Mol. Cell. Biol. 20:2529-2542.
18. Coffman, F. D., and G. P. Studzinski. 1999. Differentiation-related mechanisms which suppress DNA replication. Exp. Cell Res. 248:58-73.
19. Coker, A. L., R. B. Russell, S. M. Bond, L. Pirisi, Y. Liu, M. Mane, N. Kokorina, T. Gerasimova, and P. L. Hermonat. 2001. Adeno-associated virus is associated with a lower risk of high-grade cervical neoplasia. Exp. Mol. Pathol. 70:83-89.
20. Cukor, G., N. R. Blacklow, S. Kibrick, and I. C. Swan. 1975. Effect of adeno-associated virus on cancer expression by herpesvirus-transformed hamster cells. J. Natl. Cancer Inst. 55:957-959.
21. De Geest, K., M. E. Turyk, M. I. Hosken, J. B. Hudson, L. A. Laimins, and G. D. Wilbanks. 1993. Growth and differentiation of human papillomavirus type 31b positive human cervical cell lines. Gynecol. Oncol. 49:303-310.
22. 1/S-regulatory genes. Mol. Cell. Biol. 15:4215-4224.
23. Frattini, M. G., S. D. Hurst, H. B. Lim, S. Swaminathan, and L. A. Laimins. 1997. Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein. EMBO J. 16:318-331.
24. Friedman-Einat, M., Z. Grossman, F. Mileguir, Z. Smetana, M. Ashkenazi, G. Barkai, N. Varsano, E. Glick, and E. Mendelson. 1997. Detection of adeno-associated virus type 2 sequences in the human genital tract. J. Clin. Microbiol. 35:71-78.
25. Funk, J. O., and D. A. Galloway. 1998. Inhibiting CDK inhibitors: new lessons from DNA tumor viruses. Trends Biochem. Sci. 23:337-341.
26. Gartel, A. L., M. S. Serfas, and A. L. Tyner. 1996. p21-negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 213:138-149.
27. Georg-Fries, B., S. Biederlack, J. Wolf, and H. zur Hausen. 1984. Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology 134:64-71.
28. Gissman, L. 1992. Human papillomaviruses and genital cancer. Semin. Cancer Biol. 3:253-261.
29. Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L. H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, and E. Swindell. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387-400.
30. Hauswith, W. W. 1983. Autonomous parvovirus DNA structure and replication, p. 129-152. In K. Berns (ed.), The parvoviruses. Plenum Publishing Corp., New York, N.Y.
31. Hermanns, J., A. Schulze, P. Jansen-Dblurr, J. A. Kleinschmidt, R. Schmidt, and H. zur Hausen. 1997. Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins. J. Virol. 71:6020-6027.
32. Hermonat, P. L. 1994. Adeno-associated virus inhibits human papillomavirus type 16: a viral interaction implicated in cervical cancer. Cancer Res. 54:2278-2281.
33. Hermonat, P. L. 1989. The adeno-associated virus Rep78 gene inhibits cellular transformation induced by bovine papillomavirus. Virology 172:253-261.
34. Hermonat, P. L., R. T. Plott, A. D. Santin, G. P. Parham, and J. T. Flick. 1997. Adeno-associated virus Rep78 inhibits oncogenic transformation of primary human keratinocytes by a human papillomavirus type 16-Ras chimeric. Gynecol. Oncol. 66:487-494.
35. Hubbert, N. L., S. A. Sedman, and J. T. Schiller. 1992. Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes. J. Virol. 66:6237-6241.
36. Hunter, T., and J. Pines. 1994. Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell 79:573-582.
37. Hwang, E. S., L. K. Naeger, and D. DiMaio. 1996. Activation of the endogenous p53 growth inhibitory pathway in HeLa cervical carcinoma cells by expression of the bovine papillomavirus E2 gene. Oncogene 12:795-803.
38. Kretschmer, A., K. Moepert, S. Dames, M. Sternberger, J. Kaufmann, and A. Klippel. 2003. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4. Oncogene 22:6748-6763.
39. Lechner, M. S., D. H. Mack, A. B. Finicle, T. Crook, K. H. Vousden, and L. A. Laimins. 1992. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J. 11:3045-3052.
40. Li, Y., C. W. Jenkins, M. A. Nichols, and Y. Xiong. 1994. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9:2261-2268.
41. Macleod, K. F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:935-944.
42. Magnaghi-Jaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. Le Villain, F. Troalen, D. Trouche, and A. Harel-Bellan. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601-605.
43. 1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E. J. Virol. 72:975-985.
44. Matsukura, T., and M. Sugase. 1995. Identification of genital human papillomaviruses in cervical biopsy specimens: segregation of specific virus types in specific clinicopathologic lesions. Int. J. Cancer 61:13-22.
45. Mayor, H. D. 1993. Defective parvoviruses may be good for your health! Prog. Med. Virol. 40:193-205.
46. Mayor, H. D., S. Drake, J. Stahmann, and D. M. Mumford. 1976. Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults. Am. J. Obstet. Gynecol. 126:100-104.
47. McIntyre, M. C., M. N. Ruesch, and L. A. Laimins. 1996. Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. Virology 215:73-82.
48. McLaughlin-Drubin, M. E., and C. Meyers. 2004. Evidence for the coexistence of two genital HPV types within the same host cell in vitro. Virology 321:173-180.
49. Meyers, C. 1996. Organotypic (raft) epithelial tissue culture system for the differentiation-dependent replication of papillomavirus. Methods Cell Sci. 18:1-10.
50. Meyers, C., S. Alam, M. Mane, and P. L. Hermonat. 2001. Altered biology of adeno-associated virus type 2 and human papillomavirus during dual infection of natural host tissue. Virology 287:30-39.
51. Meyers, C., M. G. Frattini, J. B. Hudson, and L. A. Laimins. 1992. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971-973.
52. Meyers, C., M. Mane, N. Kokorina, S. Alam, and P. L. Hermonat. 2000. Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model. Virology 272:338-346.
53. Meyers, C., T. J. Mayer, and M. A. Ozbun. 1997. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 71:7381-7386.
54. Murray, E. J., G. V. Bentley, M. S. Grisanti, and S. S. Murray. 1998. The ubiquitin-proteasome system and cellular proliferation and regulation in osteoblastic cells. Exp. Cell Res. 242:460-469.
55. Ogryzko, V. V., P. Wong, and B. H. Howard. 1997. WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol. Cell. Biol. 17:4877-4882.
56. Pestell, R. G., C. Albanese, and A. T. Reutens. 1999. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr. Rev. 20:501-534.
57. Rabreau, M., and J. R. Schlehofer. 1995. Antagonism of two virus infections in the development of cervical cancer? Oncol. Rep. 2:95-97.
58. Rader, J. S., T. R. Golub, J. B. Hudson, D. Patel, M. A. Bedell, and L. A. Laimins. 1990. In vitro differentiation of epithelial cells from cervical neoplasias resembles in vivo lesions. Oncogene 5:571-576.
59. Ruesch, M., F. Stubenrauch, and L. Laimins. 1998. Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin 10. J. Virol. 72:5016-5024.
60. Saudan, P., J. Vlach, and P. Beard. 2000. Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb. EMBO J. 19:4351-4361.
61. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
62. Schlehofer, J. R. 1994. The tumor suppressive properties of adeno-associated viruses. Mutat. Res. 305:303-313.
63. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
64. 1 cyclins. Cell 73:1059-1065.
65. 1-phase progression. Genes Dev. 13:1501-1512.
66. 1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
67. Siegl, G. 1983. Biology and pathogenicity of autonomous parvoviruses, p. 297-362. In K. Berns (ed.), The parvoviruses. Plenum Publishing Corp., New York, N.Y.
68. Smith, J., R. Herrero, K. Erles, D. Grimm, N. Munoz, F. X. Bosch, L. Tafur, K. V. Shah, and J. R. Schlehofer. 2001. Adeno-associated virus seropositivity and HPV-induced cervical cancer in Spain and Colombia. Int. J. Cancer 94:520-526.
69. Snyder, R. O., X. Xiao, and J. Samulski. 1996. Production of recombinant adeno-associated viral vectors, p. 12.1.1-12.1.23. In N. C. Dracopoli et al. (ed.) Current protocols in human genetics. John Wiley and Sons, Inc., New York, N.Y.
70. Spector, D. J., and L. A. Samaniego. 1995. Construction and isolation of recombinant adenoviruses with gene replacements. Methods Mol. Genet. 7:31-44.
71. Sprecher-Goldberger, S., L. Thiry, N. Lefebvre, D. Dekegel, and F. de Halleux. 1971. Complement-fixation antibodies to adenovirus-associated viruses, cytomegaloviruses and herpes simplex viruses in patients with tumors and in control individuals. Am. J. Epidemiol. 94:351-358.
72. Su, P. F., and F. Y. Wu. 1996. Differential suppression of the tumorigenicity of HeLa and SiHa cells by adeno-associated virus. Br. J. Cancer 73:1533-1537.
73. Tobiasch, E., M. Rabreau, K. Geletneky, S. Larue-Charlus, F. Severin, N. Becker, and J. R. Schlehofer. 1994. Detection of adeno-associated virus DNA in human genital tissue and in material from spontaneous abortion. J. Med. Virol. 44:215-222.
74. Venturoli, S., M. Cricca, F. Bonvicini, G. Gallinella, G. Gentilomi, M. Zerbini, and M. Musiani. 2001. Detection of adeno-associated virus DNA in female genital samples by PCR-ELISA. J. Med. Virol. 64:577-582.
75. Waga, S., G. J. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578.
76. Walz, C., A. Deprez, T. Dupressoir, M. Durst, M. Rabreau, and J. R. Schlehofer. 1997. Interaction of human papillomavirus type 16 and adeno-associated virus type 2 co-infecting human cervical epithelium. J. Gen. Virol. 78:1441-1452.
77. Walz, C., J. R. Schlehofer, M. Flentje, V. Rudat, and H. zur Hausen. 1992. Adeno-associated virus sensitizes HeLa cell tumors to gamma rays. J. Virol. 66:5651-5657.
78. Walz, C. M., T. R. Anisi, J. R. Schlehofer, L. Gissmann, A. Schneider, and M. Muller. 1998. Detection of infectious adeno-associated virus particles in human cervical biopsies. Virology 247:97-105.
79. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
80. Yakobson, B., T. Koch, and E. Winocour. 1987. Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J. Virol. 61:972-981.
81. zur Hausen, H. 1991. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13.
82. zur Hausen, H. 1994. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr. Top. Microbiol. Immunol. 186:131-156.
83. zur Hausen, H. 1989. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res. 49:4677-4681.
84. zur Hausen, H. 1999. Papillomaviruses in human cancers. Proc. Assoc. Am. Physicians 111:581-587.
85. zur Hausen, H., and A. Schneider. 1987. The role of papillomaviruses in human anogenital cancer, p. 245-263. In N. Salzman and P. M. Howley (ed.), The papillomaviruses, vol. 2. Plenum Press, New York, N.Y.